Inquiry learning. Integrating content detail and critical reasoning by peer review.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 3038128)

Published in Science on February 29, 2008

Authors

Ravi Iyengar1, Maria A Diverse-Pierluissi, Sherry L Jenkins, Andrew M Chan, Lakshmi A Devi, Eric A Sobie, Adrian T Ting, Daniel C Weinstein

Author Affiliations

1: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, NY 10029, USA. ravi.iyengar@mssm.edu

Articles by these authors

Orphaned ryanodine receptors in the failing heart. Proc Natl Acad Sci U S A (2006) 3.99

Formation of regulatory patterns during signal propagation in a Mammalian cellular network. Science (2005) 3.48

A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A (2004) 3.00

The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep (2008) 2.65

Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41

Caspase 8 inhibits programmed necrosis by processing CYLD. Nat Cell Biol (2011) 2.37

D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol (2007) 2.28

Ubiquitination of RIP1 regulates an NF-kappaB-independent cell-death switch in TNF signaling. Curr Biol (2007) 2.15

Recovery of cardiac calcium release is controlled by sarcoplasmic reticulum refilling and ryanodine receptor sensitivity. Cardiovasc Res (2011) 1.98

mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol (2006) 1.93

Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal (2010) 1.90

Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J (2007) 1.89

G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacol Rev (2014) 1.82

Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J Immunol (2005) 1.78

A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol (2002) 1.77

Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem (2007) 1.75

Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cell (2002) 1.71

Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci U S A (2007) 1.70

The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci (2007) 1.68

Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Res (2005) 1.65

Network analysis of FDA approved drugs and their targets. Mt Sinai J Med (2007) 1.65

Regression analysis for constraining free parameters in electrophysiological models of cardiac cells. PLoS Comput Biol (2010) 1.62

Systems approach to explore components and interactions in the presynapse. Proteomics (2009) 1.61

Dynamics of calcium sparks and calcium leak in the heart. Biophys J (2011) 1.57

Cyclosporine attenuates cardiomyocyte hypertrophy induced by RAF1 mutants in Noonan and LEOPARD syndromes. J Mol Cell Cardiol (2011) 1.55

Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol Cell Proteomics (2006) 1.43

Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A (2008) 1.42

Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J (2008) 1.40

Mathematical model of the neonatal mouse ventricular action potential. Am J Physiol Heart Circ Physiol (2008) 1.37

Receptor heteromerization and drug discovery. Trends Pharmacol Sci (2010) 1.37

Conformation state-sensitive antibodies to G-protein-coupled receptors. J Biol Chem (2006) 1.37

Exploiting mathematical models to illuminate electrophysiological variability between individuals. J Physiol (2012) 1.35

Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity. Proc Natl Acad Sci U S A (2013) 1.34

Cannabinoid receptor-induced neurite outgrowth is mediated by Rap1 activation through G(alpha)o/i-triggered proteasomal degradation of Rap1GAPII. J Biol Chem (2005) 1.32

Local Ca(2+) signaling and EC coupling in heart: Ca(2+) sparks and the regulation of the [Ca(2+)](i) transient. J Mol Cell Cardiol (2002) 1.32

Exploring a role for heteromerization in GPCR signalling specificity. Biochem J (2011) 1.31

Quantification of repolarization reserve to understand interpatient variability in the response to proarrhythmic drugs: a computational analysis. Heart Rhythm (2011) 1.31

Multiple actions of spinophilin regulate mu opioid receptor function. Neuron (2008) 1.30

Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods Mol Med (2003) 1.28

G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding. Mol Pharmacol (2011) 1.27

Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol (2008) 1.26

Novel endogenous peptide agonists of cannabinoid receptors. FASEB J (2009) 1.25

NF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infection. J Virol (2003) 1.25

The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3. J Biol Chem (2005) 1.25

Calcium biology of the transverse tubules in heart. Ann N Y Acad Sci (2005) 1.22

Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiation. Proc Natl Acad Sci U S A (2007) 1.19

AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. EMBO J (2011) 1.18

An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. ScientificWorldJournal (2007) 1.18

Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma. Int J Cancer (2007) 1.17

Oligomerization of opioid receptors. Methods (2002) 1.17

Serotonin receptor activation leads to neurite outgrowth and neuronal survival. Brain Res Mol Brain Res (2005) 1.14

Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy. J Hepatol (2013) 1.12

Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling. J Biol Chem (2002) 1.11

Predicting local SR Ca(2+) dynamics during Ca(2+) wave propagation in ventricular myocytes. Biophys J (2010) 1.10

Neuropeptide processing profile in mice lacking prohormone convertase-1. Biochemistry (2005) 1.09

Therapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatment. Mol Cancer Ther (2011) 1.09

GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base. Bioinformatics (2010) 1.09

B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol (2005) 1.08

β2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4. J Cardiovasc Pharmacol (2010) 1.08

Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization. FASEB J (2010) 1.08

NEMO inhibits programmed necrosis in an NFκB-independent manner by restraining RIP1. PLoS One (2012) 1.07

PIP(2) regulates the ionic current of P2X receptors and P2X(7) receptor-mediated cell death. Channels (Austin) (2007) 1.05

Obesity and diabetes in transgenic mice expressing proSAAS. J Endocrinol (2004) 1.04

Grand opening of structure-guided design for novel opioids. Trends Pharmacol Sci (2012) 1.04

Cannabinoid receptor 2-mediated attenuation of CXCR4-tropic HIV infection in primary CD4+ T cells. PLoS One (2012) 1.03

T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. J Exp Med (2013) 1.03

Targeting opioid receptor heterodimers: strategies for screening and drug development. AAPS J (2006) 1.02

Interactions between delta opioid receptors and alpha-adrenoceptors. Clin Exp Pharmacol Physiol (2004) 1.02

Suppression of glioblastoma tumorigenicity by the Kruppel-like transcription factor KLF6. Oncogene (2004) 1.02

Cannabinoid-opioid interactions during neuropathic pain and analgesia. Curr Opin Pharmacol (2009) 1.02

Essential role for IKKgamma/NEMO in TCR-induced IL-2 expression in Jurkat T cells. Eur J Immunol (2003) 1.01

Negative regulation of TCR signaling by NF-kappaB2/p100. J Immunol (2007) 1.01

Allosteric activation of Na+-Ca2+ exchange by L-type Ca2+ current augments the trigger flux for SR Ca2+ release in ventricular myocytes. Biophys J (2008) 1.01

Allosteric interactions between δ and κ opioid receptors in peripheral sensory neurons. Mol Pharmacol (2011) 1.00

Unique properties of the ATP-sensitive K⁺ channel in the mouse ventricular cardiac conduction system. Circ Arrhythm Electrophysiol (2011) 1.00

The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications. Pharmacol Rev (2011) 0.99

Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology (2009) 0.99

Regulation of vertebrate embryogenesis by the exon junction complex core component Eif4a3. Dev Dyn (2010) 0.99

Simultaneous activation of the delta opioid receptor (deltaOR)/sensory neuron-specific receptor-4 (SNSR-4) hetero-oligomer by the mixed bivalent agonist bovine adrenal medulla peptide 22 activates SNSR-4 but inhibits deltaOR signaling. Mol Pharmacol (2006) 0.99

RIP1 comes back to life as a cell death regulator in TNFR1 signaling. FEBS J (2011) 0.98

Hemoglobin-derived peptides as novel type of bioactive signaling molecules. AAPS J (2010) 0.97

Mouse Mix gene is activated early during differentiation of ES and F9 stem cells and induces endoderm in frog embryos. Dev Dyn (2003) 0.97

Parameter sensitivity analysis of stochastic models provides insights into cardiac calcium sparks. Biophys J (2013) 0.96

The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation. J Neurochem (2010) 0.96

Xema, a foxi-class gene expressed in the gastrula stage Xenopus ectoderm, is required for the suppression of mesendoderm. Development (2005) 0.96

Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther (2006) 0.96

Moment closure for local control models of calcium-induced calcium release in cardiac myocytes. Biophys J (2008) 0.96

Insider access: pepducin symposium explores a new approach to GPCR modulation. Ann N Y Acad Sci (2009) 0.96

SNAVI: Desktop application for analysis and visualization of large-scale signaling networks. BMC Syst Biol (2009) 0.95

A probability density approach to modeling local control of calcium-induced calcium release in cardiac myocytes. Biophys J (2007) 0.95

Peptidomics of Cpefat/fat mouse hypothalamus and striatum: effect of chronic morphine administration. J Mol Neurosci (2006) 0.94

Opioid receptor heteromers in analgesia. Expert Rev Mol Med (2012) 0.94

Characterization of endothelin-converting enzyme-2. Implication for a role in the nonclassical processing of regulatory peptides. J Biol Chem (2003) 0.94

Regulation of nodal and BMP signaling by tomoregulin-1 (X7365) through novel mechanisms. Dev Biol (2003) 0.94

Processing of proSAAS in neuroendocrine cell lines. Biochem J (2002) 0.93

Rab11 regulates planar polarity and migratory behavior of multiciliated cells in Xenopus embryonic epidermis. Dev Dyn (2012) 0.93

Systems pharmacology meets predictive, preventive, personalized and participatory medicine. Pharmacogenomics (2013) 0.93

Teaching resources. Cell signaling systems: a course for graduate students. Sci STKE (2005) 0.93

Structural biology: How opioid drugs bind to receptors. Nature (2012) 0.92